• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
INGN

INGN

Inogen, Inc.

NASDAQHealthcareMedical - DevicesUS

USD5.98

-0.11 (-1.81%)

Rating:C

Company Profile

CEO

Kevin R. Smith

IPO Date

2014-02-14

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$6.11

Prev. Close

$6.09

Day Low

$5.87

Day High

$6.25

52W Low

$5.34

52W High

$9.13

Market Cap

$0.16B

Volume

0.43M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

22.8%

Avg Negative

2.1%

Avg Neutral

74.9%

News Feed

Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021

Business Wire·7/14/2021·↑ positive

Here's Why You Should Add Inogen (INGN) to Your Portfolio

Zacks Investment Research·6/23/2021·↑ positive

Inogen Announces Appointment of General Counsel

Business Wire·6/21/2021·↑ positive

Inogen Strengthens Board of Directors with Addition of Elizabeth Mora

Business Wire·5/24/2021·↑ positive

Inogen (INGN) Q1 Loss Narrower Than Expected, Revenues Beat

Zacks Investment Research·5/5/2021·↑ positive

Inogen, Inc. (INGN) CEO Nabil Shabshab on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/4/2021·↓ negative

Inogen's Earnings Outlook

Benzinga·5/3/2021·↑ positive

Inogen to Announce First Quarter 2021 Financial Results on May 4th, 2021

Business Wire·4/19/2021·↓ negative

Inogen Announces Appointment of Chief Commercial Officer, Transition of Certain Officers, and Preliminary, Unaudited First Quarter 2021 Revenue Range

Business Wire·4/7/2021·↑ positive

Inogen Announces Participation in the KeyBanc Life Sciences & MedTech Investor Forum

Business Wire·3/12/2021·↑ positive